Clinical Trial Update: A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial of tisotumab vedotin in Japanese subjects with advanced solid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Tisotumab Vedotin (tisotumab vedotin)

Snippet

Sponsor: Genmab | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED